Peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders
US7208475B2 · kind B2 · utility
2Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 2, 2004 |
| Grant date | Apr 24, 2007 |
| Priority date | — |
| Expiry date | Nov 27, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition comprising peptide HA3G76 Tyr-Leu-Ser-Lys-Gly-Arg-Leu-Val-Phe-Ala-Leu-Gly (SEQ ID NO:8).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.